R&D, strategic alliances and shareholder value in biotech industry.

The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" v...

Full description

Bibliographic Details
Main Author: Teng, Poi Leng.
Other Authors: Tan, Patricia Mui Siang
Format: Thesis
Published: 2008
Subjects:
Online Access:http://hdl.handle.net/10356/7721
_version_ 1811682531042394112
author Teng, Poi Leng.
author2 Tan, Patricia Mui Siang
author_facet Tan, Patricia Mui Siang
Teng, Poi Leng.
author_sort Teng, Poi Leng.
collection NTU
description The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital.
first_indexed 2024-10-01T03:58:19Z
format Thesis
id ntu-10356/7721
institution Nanyang Technological University
last_indexed 2024-10-01T03:58:19Z
publishDate 2008
record_format dspace
spelling ntu-10356/77212024-01-12T10:13:30Z R&D, strategic alliances and shareholder value in biotech industry. Teng, Poi Leng. Tan, Patricia Mui Siang Nanyang Business School DRNTU::Business::Industries and labor The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital. Master of Accountancy 2008-09-18T07:50:12Z 2008-09-18T07:50:12Z 2004 2004 Thesis http://hdl.handle.net/10356/7721 Nanyang Technological University application/pdf
spellingShingle DRNTU::Business::Industries and labor
Teng, Poi Leng.
R&D, strategic alliances and shareholder value in biotech industry.
title R&D, strategic alliances and shareholder value in biotech industry.
title_full R&D, strategic alliances and shareholder value in biotech industry.
title_fullStr R&D, strategic alliances and shareholder value in biotech industry.
title_full_unstemmed R&D, strategic alliances and shareholder value in biotech industry.
title_short R&D, strategic alliances and shareholder value in biotech industry.
title_sort r d strategic alliances and shareholder value in biotech industry
topic DRNTU::Business::Industries and labor
url http://hdl.handle.net/10356/7721
work_keys_str_mv AT tengpoileng rdstrategicalliancesandshareholdervalueinbiotechindustry